These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 11507947)

  • 21. Prescription drug benefits: promising solutions.
    Goff VV
    Issue Brief (Inst Health Care Costs Solut); 2002; 1(4):1-16. PubMed ID: 12825600
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reporting of drug expenditures in the MCBS.
    Poisal JA
    Health Care Financ Rev; 2003; 25(2):23-36. PubMed ID: 15124375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drugs still influence health costs, but trend abating.
    Capitation Rates Data; 2003 Oct; 8(10):114-20. PubMed ID: 14621548
    [No Abstract]   [Full Text] [Related]  

  • 24. Drug costs may top $750 PMPY by 2004.
    Capitation Rates Data; 2000 Oct; 5(10):115-8. PubMed ID: 11147537
    [No Abstract]   [Full Text] [Related]  

  • 25. Insurance benefits, out-of-pocket payments, and the demand for medical care.
    Newhouse JP
    Health Med Care Serv Rev; 1978; 1(4):1, 3-15. PubMed ID: 10297475
    [No Abstract]   [Full Text] [Related]  

  • 26. The Pharmacy-based Cost Group model: validating and adjusting the classification of medications for chronic conditions to the Dutch situation.
    Lamers LM; van Vliet RC
    Health Policy; 2004 Apr; 68(1):113-21. PubMed ID: 15033558
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The influence of prescription drug insurance on psychotropic and non-psychotropic drug utilization in Canada.
    Sarma S; Basu K; Gupta A
    Soc Sci Med; 2007 Dec; 65(12):2553-65. PubMed ID: 17761377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the effect of a consumer-driven health plan on medical care expenditures and utilization.
    Parente ST; Feldman R; Christianson JB
    Health Serv Res; 2004 Aug; 39(4 Pt 2):1189-210. PubMed ID: 15230920
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patterns of outpatient prescription drug use among Pennsylvania elderly.
    Stuart B; Ahern F; Rabatin V; Johnson A
    Health Care Financ Rev; 1991; 12(3):61-72. PubMed ID: 10113613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug use, cost benchmarks focus on senior population.
    Capitation Rates Data; 2001 Oct; 6(10):116-20. PubMed ID: 11680098
    [No Abstract]   [Full Text] [Related]  

  • 31. Riding the rollercoaster: the ups and downs in out-of-pocket spending under the standard Medicare drug benefit.
    Stuart B; Briesacher BA; Shea DG; Cooper B; Baysac FS; Limcangco MR
    Health Aff (Millwood); 2005; 24(4):1022-31. PubMed ID: 16012142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The implications of choice: prescribing generic or preferred pharmaceuticals improves medication adherence for chronic conditions.
    Shrank WH; Hoang T; Ettner SL; Glassman PA; Nair K; DeLapp D; Dirstine J; Avorn J; Asch SM
    Arch Intern Med; 2006 Feb; 166(3):332-7. PubMed ID: 16476874
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Explaining the demand for pharmaceuticals in Spain: are there differences in drug consumption between foreigners and the Spanish population?
    Jiménez-Rubio D; Hernández-Quevedo C
    Health Policy; 2010 Oct; 97(2-3):217-24. PubMed ID: 20807684
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of the PBM in total health management strategies for individuals with chronic conditions.
    Slezak J; Stine N
    Benefits Q; 2003; 19(1):38-44. PubMed ID: 12608117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Containing costs.
    Knapp DA
    Pharm Manage Comb Am J Pharm; 1979; 151(2):53-5. PubMed ID: 441144
    [No Abstract]   [Full Text] [Related]  

  • 36. Drug-related morbidity and mortality: an economic and clinical perspective.
    Bootman JL
    Manag Care; 2002 Feb; 11(2 Suppl):12-5. PubMed ID: 11907995
    [No Abstract]   [Full Text] [Related]  

  • 37. Trends in health care expenditures, utilization, and health status among US adults with spine problems, 1997-2006.
    Martin BI; Turner JA; Mirza SK; Lee MJ; Comstock BA; Deyo RA
    Spine (Phila Pa 1976); 2009 Sep; 34(19):2077-84. PubMed ID: 19675510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expenditures for prescription drugs: too much or not enough?
    Schumock GT; Walton SM
    Healthc Financ Manage; 2003 Oct; 57(10):34-8, 41. PubMed ID: 14560578
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trends in prescription drug expenditures by Medicaid enrollees.
    Banthin JS; Miller GE
    Med Care; 2006 May; 44(5 Suppl):I27-35. PubMed ID: 16625061
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The rise in spending among Medicare beneficiaries: the role of chronic disease prevalence and changes in treatment intensity.
    Thorpe KE; Howard DH
    Health Aff (Millwood); 2006; 25(5):w378-88. PubMed ID: 16926180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.